Pharmaceutical / Drug Definition :
Inhibits topoisomerase 1 (an enzyme that allows DNA replication) by binding to it. This action prevents religation of DNA strand, which results in breakage of double-stranded DNA and cell death.
FDA Label Requirements and Exceptions
Irinotecan Hydrochloride
FDA Import Information
Irinotecan Hydrochloride
FDA Detentions
Irinotecan Hydrochloride (Irinotecan Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Irinotecan Hydrochloride (Irinotecan Hydrochloride Suppliers)
- Processors Irinotecan Hydrochloride
- Repackers Irinotecan Hydrochloride
- Relabelers Irinotecan Hydrochloride
- Exporters Irinotecan Hydrochloride
- Importers Irinotecan Hydrochloride
For more information about Irinotecan Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
